Related Experiment Video
Updated: Jul 15, 2026
09:15
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Coenzyme Q10 and statins: biochemical and clinical implications
Gian Paolo Littarru1, Peter Langsjoen
1Institute of Biochemistry, Polytechnic University of the Marche, Via Ranieri, 60131 Ancona, Italy. g.littarru@univpm.it
Mitochondrion
|May 8, 2007
Summary
Statins, used for high cholesterol, can lower Coenzyme Q10 (CoQ10) levels by inhibiting its synthesis. This depletion may affect muscle and heart energy production, warranting physician awareness.
Area of Science:
- Biochemistry
- Pharmacology
- Cardiology
Background:
- Statins are effective hypercholesterolemia treatments, generally well-tolerated.
- Skeletal muscle issues and elevated CK levels are rare side effects.
- Statins inhibit HMG-CoA reductase, impacting Coenzyme Q10 (CoQ10) and dolichol synthesis.
Purpose of the Study:
- To investigate the impact of statin treatment on Coenzyme Q10 (CoQ10) levels.
- To explore the potential link between statin-induced CoQ10 depletion and adverse effects on skeletal muscle and myocardial bioenergetics.
Main Methods:
- Review of existing literature on statin therapy and CoQ10 levels.
- Analysis of CoQ10 transport mechanisms (LDL-dependent and de novo synthesis).
- Observation of CoQ10 levels in plasma, platelets, and lymphocytes of statin-treated patients.
Main Results:
- Statin treatment lowers plasma CoQ10 levels, potentially due to inhibited synthesis.
- Decreased CoQ10 levels are observed in platelets and lymphocytes, not solely LDL-dependent.
- Evidence suggests statin-induced CoQ10 depletion may be linked to subclinical cardiomyopathy, reversible with CoQ10 supplementation.
Conclusions:
- Statin therapy can significantly reduce CoQ10 levels, affecting both plasma and potentially tissue concentrations.
- Physicians should be aware of this drug-nutrient interaction and monitor patients for potential impacts on skeletal muscle and myocardial function.
- Further large-scale clinical trials are needed to confirm the benefits of CoQ10 supplementation in statin-treated patients.
Related Concept Videos
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:29Cholesterol: Significance and Regulation
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
01:25Pharmacokinetics: Drug–Drug Interactions
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
01:17Ischemic Heart Disease: Overview
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
01:24Cofactors and Coenzymes
Enzymes are proteins made of amino acids. The functional group of each constituent amino acid catalyzes a wide variety of chemical reactions via ionic interactions or acid-base reactions. However, amino acids cannot catalyze oxidation-reduction and group transfer reactions and need to be aided by non-protein components called cofactors. Cofactors are also referred to as the chemical teeth of an enzyme.
Cofactors can be metallic ions or organic molecules called coenzymes. These types of helper...
Cofactors can be metallic ions or organic molecules called coenzymes. These types of helper...
01:27Cofactors and Coenzymes
Enzymes require additional components for proper function. There are two such classes of molecules: cofactors and coenzymes. Cofactors are metallic ions and coenzymes are non-protein organic molecules. Both of these types of helper molecule can be tightly bound to the enzyme or bound only when the substrate binds.